🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Sumant Kulkarni

Stock Analyst at Canaccord Genuity

(4.35)
# 1,356
Out of 5,162 analysts
442
Total ratings
44.7%
Success rate
7.2%
Average return

Stocks Rated by Sumant Kulkarni

Annovis Bio
Nov 16, 2026
Reiterated: Buy
Price Target: $17
Current: $0.7484
Upside: +2,171.51%
GH Research
Nov 16, 2026
Reiterated: Buy
Price Target: $39
Current: $18.56
Upside: +110.13%
Zevra Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $20
Current: $9.07
Upside: +120.51%
CervoMed
Nov 10, 2026
Reiterated: Buy
Price Target: $18
Current: $1.33
Upside: +1,253.38%
Definium Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $78
Current: $29.48
Upside: +164.59%
COMPASS Pathways
Nov 9, 2026
Reiterated: Buy
Price Target: $20
Current: $8.65
Upside: +131.21%
Acadia Pharmaceuticals
Nov 6, 2026
Reiterated: Buy
Price Target: $36 → $38
Current: $17.59
Upside: +116.03%
LB Pharmaceuticals
Nov 6, 2026
Reiterated: Buy
Price Target: $65
Current: $40.04
Upside: +62.34%
Voyager Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $12
Current: $1.61
Upside: +645.34%
Neurocrine Biosciences
Nov 3, 2026
Reiterated: Buy
Price Target: $210 → $220
Current: $156.59
Upside: +40.49%
Reiterated: Buy
Price Target: $28
Current: $18.32
Upside: +52.84%
Reiterated: Buy
Price Target: $58
Current: $26.93
Upside: +115.37%
Reiterated: Buy
Price Target: $21 → $32
Current: $13.65
Upside: +134.43%
Reiterated: Buy
Price Target: $248 → $272
Current: $247.13
Upside: +10.06%
Reiterated: Buy
Price Target: $35 → $24
Current: $6.42
Upside: +273.83%
Reiterated: Buy
Price Target: $50
Current: $3.50
Upside: +1,328.57%
Downgraded: Hold
Price Target: $120 → $36
Current: $0.9461
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $16.36
Upside: n/a
Reiterated: Buy
Price Target: $66 → $53
Current: $19.88
Upside: n/a
Reiterated: Sell
Price Target: $35 → $19
Current: $21.39
Upside: n/a
Reiterated: Sell
Price Target: $109
Current: $16.04
Upside: n/a
Reiterated: Buy
Price Target: $193.70
Current: $12.30
Upside: n/a